CoChat

Subcutaneous Administration of Monoclonal Antibodies in Oncology

Open access
Jackisch, C., Müller, V., Maintz, C., Hell, S., Ataseven, B. · 2014 · Geburtshilfe und Frauenheilkunde

The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.

Abstract

Treatment with monoclonal antibodies (mabs) has become an established component of oncological therapy. The monoclonal antibodies available for this purpose are mainly administered intravenously in individually adapted doses according to body weight over longer treatment times. For other chronic diseases such as, for example, diabetes mellitus, the subcutaneous administration of drugs is an established therapy option. For the subcutaneous administration of larger volumes as needed for mab solutions the extracellular matrix of the subcutaneous tissue represents a problem. The co-formulation with recombinant human hyaluronidase makes the relatively pain-free administration of larger fluid volumes and thus the subcutaneous administration of monoclonal antibodies possible, as illustrated by the development of a subcutaneous formulation of trastuzumab. This constitutes a less invasive, time-optimised and flexible form of administration for patients with HER2-positive breast cancer that, with its fixed dosing possibilities, contributes to therapeutic safety. The example of trastuzumab shows that the subcutaneous administration of monoclonal antibodies can simplify oncological long-term therapy not only for the patients but also for the medical personnel.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1055/s-0034-1368173

Cites

25 of 25 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 25 references

Research works printed but not linked: 4

  1. Davies A, Merli F, Mihaljevic B et al. Pharmacokinetics, safety, and over- all response rate achieved with subcutaneous administration of ritux- imab in combination with chemotherapy were comparable with those achieved with intravenous administration in patients with follicular lymphoma in the first-line setting: stage 1 results of the phase 3 SAB- RINA study (BO22334). Blood (ASH Annual Meeting Abstracts) 2012; 120: 1629
  2. Haller F. Converting intravenous dosing to subcutaneous dosing with recombinant human hyaluronidase. Pharm Tech 2007; 10: 861 -864
  3. Watson D. Hyaluronidase. Br J Anaesth 1993; 71: 422-425
  4. De Cock E, Semiglazov V, Lopez-Vivanco G et al. Time savings with tras- tuzumab subcutaneous vs. intravenous administration: a time-and- motion study. Präsentiert als Poster auf der International Breast Cancer Conference St. Gallen 2013, Abstract P209, 2013

Cited by

See all 90

Metadata

Authors
Jackisch, C., Müller, V., Maintz, C., Hell, S., & Ataseven, B.
Affiliations
  • Sana Klinikum Offenbach (DE)
  • University Medical Center Hamburg-Eppendorf (DE)
  • Hämatologisch-Onkologische Praxis, Würselen
  • Medizinisch-wissenschaftliche Beratung, Speyer
  • Kliniken Essen-Mitte (DE)
Corresponding author
Jackisch, C.
Venue
Geburtshilfe und Frauenheilkunde
Published
2014-04-28
Volume
74
Issue
04
Pages
343-349
ISSN
  • 0016-5751 (ISSN-L)
  • 1438-8804
OpenAlex
W2090108443
Cited by
90
References
25
Citations by year
2026: 2 · 2025: 7 · 2024: 9 · 2023: 13 · 2022: 13 · 2021: 14 · 2020: 8 · 2019: 4 · 2018: 9 · 2017: 7 · 2016: 3 · 2015: 1
FWCI
2.87
Type
journal article
Language
de
Open access
Locations
  • Geburtshilfe und Frauenheilkunde (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Amgen
  • Les Laboratories Pierre Fabre
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › Monoclonal and Polyclonal Antibodies Research
  • Health Sciences › Medicine › Oncology › HER2/EGFR in Cancer Research
  • Life Sciences › Immunology and Microbiology › Immunology › Biosimilars and Bioanalytical Methods
Keywords
subcutaneous administration, monoclonal antibodies, trastuzumab, recombinant human hyaluronidase, subcutaneous formulation, HER2-positive breast cancer, extracellular matrix, fixed dosing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Subcutaneous Administration of Monoclonal Antibodies in Oncology. https://app.cochat.ai/papers/10.1055/s-0034-1368173
The paper
Jackisch, C., Müller, V., Maintz, C., Hell, S., & Ataseven, B. (2014). Subcutaneous Administration of Monoclonal Antibodies in Oncology. Geburtshilfe und Frauenheilkunde. https://doi.org/10.1055/s-0034-1368173

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.